Eric H. Kim

11.9k total citations
151 papers, 3.0k citations indexed

About

Eric H. Kim is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Eric H. Kim has authored 151 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Pulmonary and Respiratory Medicine, 56 papers in Surgery and 29 papers in Molecular Biology. Recurrent topics in Eric H. Kim's work include Prostate Cancer Diagnosis and Treatment (42 papers), Prostate Cancer Treatment and Research (37 papers) and Renal cell carcinoma treatment (33 papers). Eric H. Kim is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (42 papers), Prostate Cancer Treatment and Research (37 papers) and Renal cell carcinoma treatment (33 papers). Eric H. Kim collaborates with scholars based in United States, China and Canada. Eric H. Kim's co-authors include Gerald L. Andriole, R. Sherburne Figenshau, Sam B. Bhayani, Jeffrey A. Larson, Youssef S. Tanagho, Joel Vetter, Antonina Rait, Kathleen F. Pirollo, Sang Soo Kim and Esther H. Chang and has published in prestigious journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eric H. Kim

142 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric H. Kim United States 30 1.2k 823 633 281 271 151 3.0k
Cheng‐Keng Chuang Taiwan 30 910 0.8× 674 0.8× 876 1.4× 516 1.8× 329 1.2× 202 3.0k
Jun Qi China 28 701 0.6× 873 1.1× 431 0.7× 348 1.2× 156 0.6× 195 2.7k
Piergiuseppe Colombo Italy 34 1.0k 0.9× 784 1.0× 843 1.3× 869 3.1× 189 0.7× 218 4.0k
Shinya Yamamoto Japan 28 1.2k 1.1× 549 0.7× 572 0.9× 543 1.9× 91 0.3× 180 2.4k
Abel Garcı́a Garcı́a Spain 39 422 0.4× 1.3k 1.6× 611 1.0× 702 2.5× 179 0.7× 236 4.8k
Hai Huang China 33 863 0.7× 1.3k 1.6× 650 1.0× 483 1.7× 368 1.4× 160 3.3k
Giuseppe Lombardi Italy 40 857 0.7× 877 1.1× 791 1.2× 599 2.1× 328 1.2× 257 5.2k
José Antonio Rodríguez Spain 37 402 0.3× 1.0k 1.3× 506 0.8× 291 1.0× 280 1.0× 143 3.9k
Henrik Alfthan Finland 42 1.1k 0.9× 1.5k 1.8× 779 1.2× 803 2.9× 174 0.6× 135 5.7k
Karen Smith United States 33 993 0.8× 1.7k 2.0× 575 0.9× 693 2.5× 296 1.1× 103 4.9k

Countries citing papers authored by Eric H. Kim

Since Specialization
Citations

This map shows the geographic impact of Eric H. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric H. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric H. Kim more than expected).

Fields of papers citing papers by Eric H. Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric H. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric H. Kim. The network helps show where Eric H. Kim may publish in the future.

Co-authorship network of co-authors of Eric H. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Eric H. Kim. A scholar is included among the top collaborators of Eric H. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric H. Kim. Eric H. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vetter, Joel, et al.. (2024). DECIPHER® GENOMIC CLASSIFIER ON INITIAL PROSTATE BIOPSY IS ASSOCIATED WITH GLEASON SCORE UPGRADING ON FINAL RADICAL PROSTATECTOMY PATHOLOY. Urologic Oncology Seminars and Original Investigations. 42. S94–S94. 1 indexed citations
3.
Kim, Eric H. & Alana A. Lewin. (2024). Breast Density. Radiologic Clinics of North America. 62(4). 593–605. 2 indexed citations
4.
Ippolito, Joseph E., Jennifer K. Sehn, Cody Weimholt, et al.. (2024). N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic Phenotype. Molecular Cancer Research. 23(1). 59–70. 2 indexed citations
5.
Li, Tiandao, Bo Zhang, Charles U. Nottingham, et al.. (2024). Symptomatic Benign Prostatic Hyperplasia with Suppressed Epigenetic Regulator HOXB13 Shows a Lower Incidence of Prostate Cancer Development. Cancers. 16(1). 213–213. 6 indexed citations
6.
Weimholt, Cody, Jingqin Luo, Nupam P. Mahajan, et al.. (2024). Prostate-Specific Membrane Antigen–Targeted Imaging and Its Correlation with HOXB13 Expression. Journal of Nuclear Medicine. 65(8). 1210–1216.
7.
Li, Siming, Yanxia Shi, Haiying Dong, et al.. (2024). Phase 2 Trial of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma in China. Cancer Medicine. 13(21). e70368–e70368. 4 indexed citations
8.
Vetter, Joel, et al.. (2024). A Hybrid Approach to Hood-Sparing Robotic Prostatectomy to Maximize Functional Outcomes and Maintain Early Oncologic Efficacy. Journal of Endourology. 38(10). 997–1003. 1 indexed citations
9.
Drake, Bettina F., et al.. (2023). Definitive treatment and risk of death among men diagnosed with metastatic prostate cancer at the Veterans Health Administration. Annals of Epidemiology. 79. 24–31. 3 indexed citations
10.
Brooks, Anthony G., et al.. (2023). Malignant priapism: case report and update on management protocols. Translational Andrology and Urology. 12(10). 1607–1613. 1 indexed citations
11.
Nguyen, Duy T., Wei Yang, Arun Renganathan, et al.. (2022). Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer. Clinical Cancer Research. 28(18). 4131–4145. 14 indexed citations
12.
Chouhan, Surbhi, Kiran Mahajan, Arun Renganathan, et al.. (2022). Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance. Nature Communications. 13(1). 6929–6929. 36 indexed citations
13.
Andriole, Gerald L., et al.. (2022). Feasibility of Robotic Partial Prostatectomy for Isolated Anterior Prostate Cancer. Videourology. 36(6).
14.
Chauhan, Pradeep S., Kevin Chen, Wenjia Feng, et al.. (2021). Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study. PLoS Medicine. 18(8). e1003732–e1003732. 55 indexed citations
15.
Figenshau, R. Sherburne, et al.. (2021). Retzius-Sparing Robot-Assisted Laparoscopic Prostatectomy with DaVinci Single-Port Robot. Videourology. 35(7). 2 indexed citations
16.
18.
Vetter, Joel, et al.. (2020). Ten-Year Experience with Percutaneous Cryoablation of Renal Tumors: Tumor Size Predicts Disease Progression. Journal of Endourology. 34(12). 1211–1217. 20 indexed citations
19.
Lake, Blue B., Song Chen, Masato Hoshi, et al.. (2019). A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys. Nature Communications. 10(1). 2832–2832. 164 indexed citations
20.
Weaver, John, Eric H. Kim, Joel Vetter, et al.. (2017). Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram. Urology. 113. 119–128. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026